Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
Mallardo D, Simeone E, Festino L, Tuffanelli M, Vanella V, Trojaniello C, Vitale MG, Ottaviano M, Capone M, Madonna G, Sparano F, Cioli E, Scarpato L, Palla M, Di Trolio R, Meinardi P, Caracò C, Ferrara G, Muto P, Cavalcanti E, Ascierto PA. Mallardo D, et al. Among authors: simeone e. J Transl Med. 2023 Feb 23;21(1):140. doi: 10.1186/s12967-023-03971-5. J Transl Med. 2023. PMID: 36823670 Free PMC article.
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
Mallardo D, Fordellone M, White A, Ottaviano M, Sparano F, Bailey M, Facchini AB, Ong S, Maiolino P, Caracò C, Church S, Cavalcanti E, Warren S, Budillon A, Cesano A, Simeone E, Chiodini P, Ascierto PA. Mallardo D, et al. Among authors: simeone e. J Transl Med. 2023 Sep 8;21(1):610. doi: 10.1186/s12967-023-04419-6. J Transl Med. 2023. PMID: 37684649 Free PMC article.
[Hyperlucent lung in ambulatory practice].
Ferrara G, Bonarrigo N, Simeone E. Ferrara G, et al. Among authors: simeone e. Arch Tisiol Mal Appar Respir. 1968 Mar;23(3):241-55. Arch Tisiol Mal Appar Respir. 1968. PMID: 5307450 Italian. No abstract available.
Correction to: Correlation between IPSET‑t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Tosoni L, Liberi M, Morelli G, Zannier ME, Lazzarotto D, Filì C, Simeone E, Battaglia G, Callegari C, Fanin M, Damiani D, Fanin R, Tiribelli M. Tosoni L, et al. Among authors: simeone e. Ann Hematol. 2024 Feb;103(2):449. doi: 10.1007/s00277-023-05608-5. Ann Hematol. 2024. PMID: 38157002 No abstract available.
Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Tosoni L, Liberi M, Morelli G, Zannier ME, Lazzarotto D, Filì C, Simeone E, Battaglia G, Callegari C, Fanin M, Damiani D, Fanin R, Tiribelli M. Tosoni L, et al. Among authors: simeone e. Ann Hematol. 2024 Feb;103(2):443-448. doi: 10.1007/s00277-023-05578-8. Epub 2023 Dec 11. Ann Hematol. 2024. PMID: 38072850
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab.
Mallardo D, Woodford R, Menzies AM, Zimmer L, Williamson A, Ramelyte E, Dimitriou F, Wicky A, Wallace R, Mallardo M, Cortellini A, Budillon A, Atkinson V, Sandhu S, Olivier M, Dummer R, Lorigan P, Schadendorf D, Long GV, Simeone E, Ascierto PA. Mallardo D, et al. Among authors: simeone e. J Transl Med. 2023 Oct 25;21(1):753. doi: 10.1186/s12967-023-04607-4. J Transl Med. 2023. PMID: 37880788 Free PMC article.
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile.
Ascierto PA, Di Giacomo AM, Chiarion Sileni V, Queirolo P, Spagnolo F, De Galitiis F, Cognetti F, Mandalà M, Guidoboni M, Rinaldi G, Depenni R, Consoli F, Troiani T, Guida M, Marconcini R, Ferrucci PF, Strippoli S, Fava P, Merelli B, Simeone E, Di Guardo L, Giannarelli D, Maio M, Quaglino P, Del Vecchio M. Ascierto PA, et al. Among authors: simeone e. Eur J Cancer. 2023 Sep;191:113246. doi: 10.1016/j.ejca.2023.113246. Epub 2023 Jul 19. Eur J Cancer. 2023. PMID: 37549531
Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps.
Modestino L, Cristinziano L, Trocchia M, Ventrici A, Capone M, Madonna G, Loffredo S, Ferrara AL, Romanelli M, Simeone E, Varricchi G, Rossi FW, de Paulis A, Marone G, Ascierto PA, Galdiero MR. Modestino L, et al. Among authors: simeone e. Cancer Immunol Immunother. 2023 Oct;72(10):3363-3376. doi: 10.1007/s00262-023-03493-5. Epub 2023 Jul 31. Cancer Immunol Immunother. 2023. PMID: 37525065 Free PMC article.
156 results